Active surveillance followed by delayed curative treatment for those who develop evidence of significant prostate cancer progression, is now a recognised management strategy for a select group of men with low risk prostate cancer. The prognosis of prostate cancer has changed dramatically over the last few decades.  Recent advances in cancer detection and prostate specific antigen blood test screening has resulted in the diagnosis of many men with small slow growing prostate cancers, which may never be a threat to your health or life expectancy. Treatment of this low risk prostate cancer (over treatment) can lead to potential serious complications … Continue reading Active Surveillance